InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Shabbir Anik. Director active across 1 company, notably Sutro Biopharma, INC.. In total, 5 reports have been logged. History available since 24 September 2021. The latest transaction was filed on 27 January 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Shabbir Anik is a director at Sutro Biopharma, INC.